Showing results 6 to 6 of 6
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology | 2010 | 53 |